Suitable patients.
LSWT is ideal for men with vasculogenic erectile dysfunction for whom PDE-5 inhibitors are ineffective or contraindicated.
Preliminary clinical data show that LSWT is effective in roughly 70% of men, whether they respond to PDE-5 inhibitors or not.
Sexual dysfunction after prostate cancer treatment.
Renova is a treatment for vasculogenic erectile dysfunction. After radical prostatectomy, the primary cause of ED is neurogenic, and Renova is not an appropriate management option. Men with erectile dysfunction following radical prostatectomy do have many treatment options.
Penile Low-Intensity Shock Wave Therapy: A Promising Novel Modality for Erectile Dysfunction.
|
